This can include lackluster education on how to dose the medications, lack of awareness around side effects, and more
The current medical consensus, reflected in obesity medicine guidelines from organizations such as the American Gastroenterological Association and Obesity Medicine Association, treats obesity as a chronic disease requiring long-term pharmacological management in most cases, similar to hypertension or hyperlipidemia
Weeks 4-12: Dose Titration and Increasing Effects As your provider increases your dose over the second and third months, the appetite-suppressing effects often become more pronounced
These medications are often prescribed alongside lifestyle changes like diet and exercise, especially for people with obesity or prediabetes who havent had success with weight loss on their own
Others are approved for type 2 diabetes and may lead to weight loss as a secondary effect
The key word is unsweetened